WOLFGANG WINKELMAYER to Diabetic Nephropathies
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Diabetic Nephropathies.
Connection Strength
1.935
-
Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis. Eur Heart J. 2019 03 14; 40(11):887-898.
Score: 0.586
-
Treatment of Hyperkalemia: From "Hyper K+" Strikeout to Home Run? JAMA. 2015 Jul 14; 314(2):129-30.
Score: 0.454
-
Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes. Diabetes Care. 2006 Oct; 29(10):2210-7.
Score: 0.247
-
Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease. J Diabetes Complications. 2019 11; 33(11):107423.
Score: 0.151
-
Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1842-1850.
Score: 0.144
-
Diabetes Control and the Risks of ESRD and Mortality in?Patients?With CKD. Am J Kidney Dis. 2017 Aug; 70(2):191-198.
Score: 0.127
-
Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis. Am J Kidney Dis. 2012 Sep; 60(3):473-86.
Score: 0.091
-
ACE inhibitor and angiotensin II type 1 receptor antagonist therapies in elderly patients with diabetes mellitus: are they underutilized? Drugs Aging. 2010 Feb 01; 27(2):87-94.
Score: 0.078
-
Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis. 2005 Aug; 46(2):225-32.
Score: 0.057